Literature DB >> 24923418

Is physiotherapy effective in the management of child and adolescent conversion disorder? A systematic review.

Tara L FitzGerald1, Alesha K Southby, Terrence P Haines, Janet P Hough, Elizabeth H Skinner.   

Abstract

Child and adolescent conversion disorder has the potential to impart significant burden on health-care services and affect quality of life. Clinically, physiotherapists are involved in conversion disorder management; however, no systematic reviews have examined physiotherapy effectiveness in its management. The aim of this review is to identify the efficacy of physiotherapy management of child and adolescent conversion disorder. A search of multiple databases (Medline, CINAHL, Embase, PsychINFO, PEDro and the Cochrane Library) was completed along with manual searching of relevant reference lists to identify articles including children 0-18 years with a diagnosis of conversion disorder who received physical management. Two independent reviewers screened titles and abstracts using criteria. Data were extracted regarding study characteristics, functional outcome measures, length of stay, physiotherapy service duration and resolution of conversion symptoms. Methodological quality was assessed using a tool designed for observational studies. Twelve observational studies were included. No functional outcome measures were used to assess the effectiveness of the treatment protocols in the case studies. Resolution of symptoms occurred in all but two cases, with conversion symptoms still present at 11 months and at 2 years. Length of stay varied from 3 days to 16 weeks, with similar variation evident in length of physiotherapy service provision (2.5 weeks to 16 weeks). There was limited and poor quality evidence to establish the efficacy of physiotherapy management of child and adolescent conversion disorders. More rigorous study designs with consistent use of reliable, valid and sensitive functional outcome measures are needed in this area.
© 2014 The Authors. Journal of Paediatrics and Child Health © 2014 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Keywords:  adolescent; behavioural; mental health/psychiatry; rehabilitation

Mesh:

Year:  2014        PMID: 24923418     DOI: 10.1111/jpc.12630

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  6 in total

1.  Evidence-Based Practice: Physiotherapy for Children and Adolescents with Motor Symptoms of Conversion Disorder.

Authors:  Giulia Mesaroli; Catherine Munns; Claire DeSouza
Journal:  Physiother Can       Date:  2019       Impact factor: 1.037

2.  Functional Neurological Symptom Disorder in Children and Adolescents within Medical Settings.

Authors:  Karen E Weiss; Kyle J Steinman; Ian Kodish; Leslie Sim; Sharon Yurs; Celeste Steggall; Aaron D Fobian
Journal:  J Clin Psychol Med Settings       Date:  2021-03

3.  Treatment of Functional Gait Abnormality in a Rehabilitation Setting: Emphasizing the Physical Interventions for Treating the Whole Child.

Authors:  Catherine Butz; Cindy Iske; Natalie Truba; Kristen Trott
Journal:  Innov Clin Neurosci       Date:  2019-07-01

4.  Psychosocial interventions for conversion and dissociative disorders in adults.

Authors:  Christina A Ganslev; Ole Jakob Storebø; Henriette E Callesen; Rachel Ruddy; Ulf Søgaard
Journal:  Cochrane Database Syst Rev       Date:  2020-07-17

5.  An adolescent with significant emotional and medically unexplained complaints: case report and proposal of an intervention.

Authors:  Alemayehu Negash; Mubarek Abera; Christine Gruber-Frank; Reiner Frank
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2015-10-15       Impact factor: 3.033

Review 6.  Efficacy of physiotherapy treatments in children and adolescents with somatic symptom disorder and other related disorders: systematic review of the literature.

Authors:  Roberta Sartori; Antimo Tessitore; Aurora Della Torca; Egidio Barbi
Journal:  Ital J Pediatr       Date:  2022-07-27       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.